GERN
Price
$1.35
Change
-$0.11 (-7.48%)
Updated
Apr 4, 03:47 PM (EDT)
Capitalization
1.01B
38 days until earnings call
LIANY
Price
$0.20
Change
-$0.00 (-0.00%)
Updated
Apr 3 closing price
Capitalization
21.59M
35 days until earnings call
Ad is loading...

GERN vs LIANY

Header iconGERN vs LIANY Comparison
Open Charts GERN vs LIANYBanner chart's image
Geron
Price$1.35
Change-$0.11 (-7.48%)
Volume$52.5K
Capitalization1.01B
LianBio
Price$0.20
Change-$0.00 (-0.00%)
Volume$1.86K
Capitalization21.59M
GERN vs LIANY Comparison Chart
Loading...
GERN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GERN vs. LIANY commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GERN is a Hold and LIANY is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (GERN: $1.47 vs. LIANY: $0.20)
Brand notoriety: GERN and LIANY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GERN: 62% vs. LIANY: 10%
Market capitalization -- GERN: $1.01B vs. LIANY: $21.59M
GERN [@Biotechnology] is valued at $1.01B. LIANY’s [@Biotechnology] market capitalization is $21.59M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GERN’s FA Score shows that 0 FA rating(s) are green whileLIANY’s FA Score has 1 green FA rating(s).

  • GERN’s FA Score: 0 green, 5 red.
  • LIANY’s FA Score: 1 green, 4 red.
According to our system of comparison, LIANY is a better buy in the long-term than GERN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GERN’s TA Score shows that 5 TA indicator(s) are bullish.

  • GERN’s TA Score: 5 bullish, 3 bearish.

Price Growth

GERN (@Biotechnology) experienced а -10.91% price change this week, while LIANY (@Biotechnology) price change was +5.21% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -11.26%. For the same industry, the average monthly price growth was -17.11%, and the average quarterly price growth was -18.89%.

Reported Earning Dates

GERN is expected to report earnings on May 12, 2025.

LIANY is expected to report earnings on May 09, 2025.

Industries' Descriptions

@Biotechnology (-11.26% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GERN($1.01B) has a higher market cap than LIANY($21.6M). LIANY YTD gains are higher at: -24.604 vs. GERN (-58.475).
GERNLIANYGERN / LIANY
Capitalization1.01B21.6M4,690%
EBITDA-154.85MN/A-
Gain YTD-58.475-24.604238%
P/E RatioN/AN/A-
Revenue77MN/A-
Total Cash407MN/A-
Total Debt122MN/A-
FUNDAMENTALS RATINGS
GERN: Fundamental Ratings
GERN
OUTLOOK RATING
1..100
72
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
PROFIT vs RISK RATING
1..100
84
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
92
P/E GROWTH RATING
1..100
66
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GERN
RSI
ODDS (%)
Bullish Trend 2 days ago
70%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
76%
Momentum
ODDS (%)
Bearish Trend 2 days ago
78%
MACD
ODDS (%)
Bullish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 15 days ago
76%
Declines
ODDS (%)
Bearish Trend 4 days ago
75%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
79%
Aroon
ODDS (%)
Bearish Trend 2 days ago
77%
View a ticker or compare two or three
Ad is loading...
GERN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GHTMX13.49N/A
N/A
Goldman Sachs International T/M Eq Instl
EISMX40.33N/A
N/A
Eaton Vance Atlanta Capital SMID-Cap I
RYMCX6.95N/A
N/A
Royce Micro-Cap Consult
BFGIX46.50N/A
N/A
Baron Focused Growth Institutional
TTDAX9.53N/A
N/A
Toews Tactical Defensive Alpha

LIANY and

Correlation & Price change

A.I.dvisor indicates that over the last year, LIANY has been closely correlated with SER. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if LIANY jumps, then SER could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LIANY
1D Price
Change %
LIANY100%
N/A
SER - LIANY
69%
Closely correlated
+1.86%
GERN - LIANY
53%
Loosely correlated
-7.55%
TRML - LIANY
28%
Poorly correlated
-2.09%
OTLK - LIANY
23%
Poorly correlated
-3.20%
MTNB - LIANY
21%
Poorly correlated
-1.52%
More